Iwqol-lite-ct — Pdf

The IWQOL-Lite-CT (Impact of Weight on Quality of Life-Lite Clinical Trials Version) was developed as a 20-item, patient-reported outcome measure specifically designed for clinical trials, focusing on physical and psychosocial impacts of weight. It offers a validated, 0–100 scale, widely used in obesity treatments to demonstrate improvements in patient-reported quality of life. For detailed validation information and the study, visit RTI Health Solutions .

"I'm here, Thomas," Elias said, forcing a smile. "Just updating your file."

The tool is considered a "gold standard" for assessing weight-related functioning in trials for medications like (Wegovy/Ozempic). Research indicates it is highly sensitive to changes in weight, particularly for detecting improvements in physical mobility and self-esteem following a weight loss of 10% or more.

The use of IWQOL-Lite-CT in clinical trials allows researchers to systematically evaluate the benefits of weight loss treatments from the patient's perspective. This includes improvements in physical functioning, emotional well-being, and social interactions. The data collected can inform regulatory, reimbursement, and clinical decision-making processes.